INS and type 1 diabetes mellitus: When combined with the ability to generate patient-derived iPSC and the advance of in vitro differentiation of iPSC into insulin-producing β-cells and hematopoietic stem cells, it may be possible to test the function of a SNP in cell types relevant to T1D (116, 117).